Episode # 204 • 06 Dec 2024
Managing Low & Intermediate Risk Bladder Cancer
Stay up to date in your bladder cancer practice with this insightful episode of the BackTable Urology podcast, developed in collaboration with the Society of Urologic Oncology. Dr. Betsy Koehne (University of Wisconsin) and Dr. Amir Salmasi (UC San Diego) talk through the contemporary management of low and intermediate-risk non-muscle-invasive bladder cancer.
This podcast was developed in collaboration with Society of Urologic Oncology.
Timestamps
00:00 - Introduction
01:51 - Initial Consultation
08:01 - TURBT Procedure Insights
23:14 - Managing Low and Intermediate Risk Bladder Cancer
26:47 - Recurrence and Surveillance Strategies
27:48 - Prognostication Tools
30:10 - Intravesical Chemotherapy Options
33:24 - High Grade Tumors
42:33 - Clinical Trials and Emerging Therapies
49:19 - Concluding Thoughts
You may also like
More about this episode
The doctors explore the challenges and nuances of patient communication, intravesical therapy, and postoperative surveillance. They also cover emerging treatments and clinical trials that hold promise for improving patient outcomes and quality of life. Emphasis is placed on the distress experienced by patients and the need for personalized treatments.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.